# Euronet Worldwide, Inc.: financial statements, quarterly

EEFT · Nasdaq · CIK 1029199 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eeft.md) · [Financials](/companies/eeft/financials.md) · [Filings](/companies/eeft/filings.md) · [Insiders](/companies/eeft/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eeft/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,004](/filings/0001213900-24-094099.md) | [958 d](/filings/0001554855-26-000131.md) | [857](/filings/0001213900-25-040380.md) | [986](/filings/0001554855-25-000919.md) | [1,099](/filings/0001554855-25-001937.md) | [1,047 d](/filings/0001554855-26-000131.md) | [916](/filings/0001554855-26-000931.md) | [1,074](/filings/0001554855-26-001702.md) | [1,146](/filings/0001554855-25-001937.md) | [1,109 d](/filings/0001554855-26-000131.md) | [1,012](/filings/0001554855-26-000931.md) | [1,108](/filings/0001554855-26-001702.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [73.9](/filings/0001213900-24-094099.md) | [72.4 d](/filings/0001554855-26-000131.md) | [71.9](/filings/0001213900-25-040380.md) | [79.4](/filings/0001554855-25-000919.md) | [80.6](/filings/0001554855-25-001937.md) | [83.4 d](/filings/0001554855-26-000131.md) | [83.0](/filings/0001554855-26-000931.md) | [87.8](/filings/0001554855-26-001702.md) | [84.6](/filings/0001554855-25-001937.md) | [117 d](/filings/0001554855-26-000131.md) | [92.6](/filings/0001554855-26-000931.md) | [98.4](/filings/0001554855-26-001702.md) |
| Operating income | $m | [167](/filings/0001213900-24-094099.md) | [97.4 d](/filings/0001554855-26-000131.md) | [64.0](/filings/0001213900-25-040380.md) | [134](/filings/0001554855-25-000919.md) | [182](/filings/0001554855-25-001937.md) | [123 d](/filings/0001554855-26-000131.md) | [75.2](/filings/0001554855-26-000931.md) | [159](/filings/0001554855-26-001702.md) | [195](/filings/0001554855-25-001937.md) | [101 d](/filings/0001554855-26-000131.md) | [72.0](/filings/0001554855-26-000931.md) | [137](/filings/0001554855-26-001702.md) |
| Interest expense | $m | [15.0](/filings/0001213900-23-083536.md) | [16.5 d](/filings/0001213900-24-016204.md) | [14.9](/filings/0001213900-24-039798.md) | [20.1](/filings/0001554855-25-000919.md) | [24.2](/filings/0001554855-25-001937.md) | [21.3 d](/filings/0001554855-26-000131.md) | [19.4](/filings/0001554855-26-000931.md) | [28.2](/filings/0001554855-26-001702.md) | [22.5](/filings/0001554855-25-001937.md) | [14.4 d](/filings/0001554855-26-000131.md) | [14.1](/filings/0001554855-26-000931.md) | [20.6](/filings/0001554855-26-001702.md) |
| Income tax | $m | [43.0](/filings/0001213900-24-094099.md) | [28.4 d](/filings/0001554855-26-000131.md) | [16.0](/filings/0001213900-25-040380.md) | [39.2](/filings/0001554855-25-000919.md) | [56.8](/filings/0001554855-25-001937.md) | [30.6 d](/filings/0001554855-26-000131.md) | [7.1](/filings/0001554855-26-000931.md) | [33.6](/filings/0001554855-26-001702.md) | [55.1](/filings/0001554855-25-001937.md) | [39.4 d](/filings/0001554855-26-000131.md) | [29.0](/filings/0001554855-26-000931.md) | [46.7](/filings/0001554855-26-001702.md) |
| Net income | $m | [104](/filings/0001213900-24-094099.md) | [69.3 d](/filings/0001554855-26-000131.md) | [26.2](/filings/0001213900-25-040380.md) | [83.1](/filings/0001554855-25-000919.md) | [152](/filings/0001554855-25-001937.md) | [45.2 d](/filings/0001554855-26-000131.md) | [38.4](/filings/0001554855-26-000931.md) | [97.6](/filings/0001554855-26-001702.md) | [122](/filings/0001554855-25-001937.md) | [51.5 d](/filings/0001554855-26-000131.md) | [37.5](/filings/0001554855-26-000931.md) | [77.4](/filings/0001554855-26-001702.md) |
| Diluted EPS | $ per share | [2.05](/filings/0001213900-24-094099.md) | not reported | [0.55](/filings/0001213900-25-040380.md) | [1.73](/filings/0001554855-25-000919.md) | [3.21](/filings/0001554855-25-001937.md) | not reported | [0.85](/filings/0001554855-26-000931.md) | [2.27](/filings/0001554855-26-001702.md) | [2.75](/filings/0001554855-25-001937.md) | not reported | [0.83](/filings/0001554855-26-000931.md) | [1.71](/filings/0001554855-26-001702.md) |
| Basic EPS | $ per share | [2.15](/filings/0001213900-24-094099.md) | not reported | [0.57](/filings/0001213900-25-040380.md) | [1.83](/filings/0001554855-25-000919.md) | [3.41](/filings/0001554855-25-001937.md) | not reported | [0.88](/filings/0001554855-26-000931.md) | [2.31](/filings/0001554855-26-001702.md) | [3.02](/filings/0001554855-25-001937.md) | not reported | [0.96](/filings/0001554855-26-000931.md) | [2.04](/filings/0001554855-26-001702.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,074](/filings/0001213900-24-094099.md) | [1,254](/filings/0001554855-26-000131.md) | [1,236](/filings/0001213900-25-040380.md) | [1,272](/filings/0001554855-25-000919.md) | [1,524](/filings/0001554855-25-001937.md) | [1,279](/filings/0001554855-26-001702.md) | [1,394](/filings/0001554855-26-000931.md) | [1,329](/filings/0001554855-26-001702.md) | [1,173](/filings/0001554855-25-001937.md) | [1,040](/filings/0001554855-26-001702.md) | [1,230](/filings/0001554855-26-000931.md) | [1,197](/filings/0001554855-26-001702.md) |
| Current assets | $m | [3,536](/filings/0001213900-23-083536.md) | [4,163](/filings/0001213900-25-017068.md) | [3,928](/filings/0001213900-24-039798.md) | [4,267](/filings/0001213900-24-064727.md) | [4,386](/filings/0001213900-24-094099.md) | [4,037](/filings/0001554855-26-000131.md) | [4,174](/filings/0001213900-25-040380.md) | [4,536](/filings/0001554855-25-000919.md) | [4,241](/filings/0001554855-25-001937.md) | [4,270](/filings/0001554855-26-001702.md) | [4,164](/filings/0001554855-26-000931.md) | [4,332](/filings/0001554855-26-001702.md) |
| Total assets | $m | [5,163](/filings/0001213900-23-083536.md) | [5,894](/filings/0001554855-26-000131.md) | [5,694](/filings/0001213900-24-039798.md) | [6,061](/filings/0001213900-24-064727.md) | [6,289](/filings/0001213900-24-094099.md) | [5,835](/filings/0001554855-26-000131.md) | [6,054](/filings/0001213900-25-040380.md) | [6,555](/filings/0001554855-25-000919.md) | [6,275](/filings/0001554855-25-001937.md) | [6,489](/filings/0001554855-26-001702.md) | [6,332](/filings/0001554855-26-000931.md) | [6,493](/filings/0001554855-26-001702.md) |
| Current liabilities | $m | [2,569](/filings/0001213900-23-083536.md) | [2,701](/filings/0001213900-25-017068.md) | [2,957](/filings/0001213900-24-039798.md) | [3,572](/filings/0001213900-24-064727.md) | [3,471](/filings/0001213900-24-094099.md) | [3,226](/filings/0001554855-26-000131.md) | [2,608](/filings/0001213900-25-040380.md) | [3,935](/filings/0001554855-25-000919.md) | [3,673](/filings/0001554855-25-001937.md) | [3,855](/filings/0001554855-26-001702.md) | [3,260](/filings/0001554855-26-000931.md) | [3,160](/filings/0001554855-26-001702.md) |
| Total liabilities | $m | [4,021](/filings/0001213900-23-083536.md) | [4,645](/filings/0001213900-25-017068.md) | [4,450](/filings/0001213900-24-039798.md) | [4,847](/filings/0001213900-24-064727.md) | [4,927](/filings/0001213900-24-094099.md) | [4,605](/filings/0001554855-26-000131.md) | [4,752](/filings/0001213900-25-040380.md) | [5,192](/filings/0001554855-25-000919.md) | [4,997](/filings/0001554855-25-001937.md) | [5,166](/filings/0001554855-26-001702.md) | [5,105](/filings/0001554855-26-000931.md) | [5,248](/filings/0001554855-26-001702.md) |
| Long-term debt | $m | [1,263](/filings/0001213900-23-083536.md) | [1,715](/filings/0001213900-25-017068.md) | [1,259](/filings/0001213900-24-039798.md) | [1,033](/filings/0001213900-24-064727.md) | [1,196](/filings/0001213900-24-094099.md) | [1,134](/filings/0001554855-26-000131.md) | [1,906](/filings/0001213900-25-040380.md) | [1,002](/filings/0001554855-25-000919.md) | [1,071](/filings/0001554855-25-001937.md) | [1,038](/filings/0001554855-26-001702.md) | [1,585](/filings/0001554855-26-000931.md) | [1,827](/filings/0001554855-26-001702.md) |
| Current portion of debt | $m | [450](/filings/0001213900-23-083536.md) | [813](/filings/0001213900-25-040380.md) | [294](/filings/0001213900-25-040380.md) | [1,234](/filings/0001213900-24-064727.md) | [1,080](/filings/0001213900-24-094099.md) | [813](/filings/0001554855-26-000131.md) | [294](/filings/0001213900-25-040380.md) | [1,434](/filings/0001554855-25-000919.md) | [1,232](/filings/0001554855-25-001937.md) | [983](/filings/0001554855-26-001702.md) | [970](/filings/0001554855-26-000931.md) | [826](/filings/0001554855-26-001702.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,143](/filings/0001213900-23-083536.md) | [1,250](/filings/0001213900-25-017068.md) | [1,244](/filings/0001213900-24-039798.md) | [1,214](/filings/0001213900-24-064727.md) | [1,362](/filings/0001213900-24-094099.md) | [1,229](/filings/0001554855-26-000131.md) | [1,302](/filings/0001213900-25-040380.md) | [1,352](/filings/0001554855-25-000919.md) | [1,263](/filings/0001554855-25-001937.md) | [1,308](/filings/0001554855-26-001702.md) | [1,211](/filings/0001554855-26-000931.md) | [1,230](/filings/0001554855-26-001702.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [287 d](/filings/0001213900-24-094099.md) | [136 d](/filings/0001554855-26-000131.md) | [30.0](/filings/0001213900-25-040380.md) | [182 d](/filings/0001554855-25-000919.md) | [440 d](/filings/0001554855-25-001937.md) | [80.3 d](/filings/0001554855-26-000131.md) | [1.7](/filings/0001554855-26-000931.md) | [183 d](/filings/0001554855-26-001702.md) | [197 d](/filings/0001554855-25-001937.md) | [178 d](/filings/0001554855-26-000131.md) | [(122)](/filings/0001554855-26-000931.md) | [148 d](/filings/0001554855-26-001702.md) |
| Capital expenditure | $m | [27.2 d](/filings/0001213900-24-094099.md) | [25.3 d](/filings/0001554855-26-000131.md) | [23.8](/filings/0001213900-25-040380.md) | [33.4 d](/filings/0001554855-25-000919.md) | [25.8 d](/filings/0001554855-25-001937.md) | [34.2 d](/filings/0001554855-26-000131.md) | [23.4](/filings/0001554855-26-000931.md) | [34.4 d](/filings/0001554855-26-001702.md) | [36.1 d](/filings/0001554855-25-001937.md) | [31.6 d](/filings/0001554855-26-000131.md) | [28.5](/filings/0001554855-26-000931.md) | [36.1 d](/filings/0001554855-26-001702.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [52.8](/filings/0001213900-23-083536.md) | [53.0](/filings/0001213900-24-039798.md) | [52.9](/filings/0001213900-24-064727.md) | [51.5](/filings/0001213900-24-094099.md) | [49.0](/filings/0001213900-25-040380.md) | [48.7](/filings/0001554855-25-000919.md) | [47.6](/filings/0001554855-25-001937.md) | [46.2](/filings/0001554855-26-000931.md) | [43.0](/filings/0001554855-26-001702.md) | [44.8](/filings/0001554855-25-001937.md) | [47.0](/filings/0001554855-26-000931.md) | [46.2](/filings/0001554855-26-001702.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,403,595 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001554855-26-001702.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.